Cargando…

Controlled infusion of intravenous cardiac drugs using global optimization

OBJECTIVES: The objective of the study is to develop an automatic drug infusion control system during cardiovascular surgery. MATERIALS AND METHODS: Based on the clinical drug dosage analysis, the modeling of cardiovascular system with baroreceptor model is mathematically modeled using compartmental...

Descripción completa

Detalles Bibliográficos
Autores principales: Sowparnika, G. C., Thirumarimurugan, M., Sivakumar, V. M., Vinoth, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444840/
https://www.ncbi.nlm.nih.gov/pubmed/31031469
http://dx.doi.org/10.4103/ijp.IJP_612_18
_version_ 1783408091298004992
author Sowparnika, G. C.
Thirumarimurugan, M.
Sivakumar, V. M.
Vinoth, N.
author_facet Sowparnika, G. C.
Thirumarimurugan, M.
Sivakumar, V. M.
Vinoth, N.
author_sort Sowparnika, G. C.
collection PubMed
description OBJECTIVES: The objective of the study is to develop an automatic drug infusion control system during cardiovascular surgery. MATERIALS AND METHODS: Based on the clinical drug dosage analysis, the modeling of cardiovascular system with baroreceptor model is mathematically modeled using compartmental approach, considering the relationship between the volume and flow rate of blood during each heartbeat. This model is then combined with drug modeling of noradrenaline and nitroglycerine by deriving the volume and drug mass concentration equations, based on pharmacokinetics and pharmacodynamics of the drugs. The closed-loop patient models are derived from the open-loop data obtained from the physiology-drug model with covariate as age. The proportional-integral controller is designed based on optimal values obtained from bacterial foraging-oriented particle swarm optimization algorithm. The controllers are implemented individually for each control variable such as aortic pressure and cardiac output (CO), irrespective of varying weights based on the relative gain array analysis which depicts the maximum influence of cardiac drugs on control variables. RESULTS: The physiology-drug model output responses are simulated using MATLAB. The controlled responses of aortic pressure and CO with infusion rate of cardiac drugs are obtained. The robustness of the controller is checked by introducing variations in cardiovascular model parameters. The efficiency of the controller during normal and abnormal conditions is compared using time domain analysis. CONCLUSIONS: The controller design was efficient and can be further improved by designing switching-based controllers.
format Online
Article
Text
id pubmed-6444840
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-64448402019-04-26 Controlled infusion of intravenous cardiac drugs using global optimization Sowparnika, G. C. Thirumarimurugan, M. Sivakumar, V. M. Vinoth, N. Indian J Pharmacol Research Article OBJECTIVES: The objective of the study is to develop an automatic drug infusion control system during cardiovascular surgery. MATERIALS AND METHODS: Based on the clinical drug dosage analysis, the modeling of cardiovascular system with baroreceptor model is mathematically modeled using compartmental approach, considering the relationship between the volume and flow rate of blood during each heartbeat. This model is then combined with drug modeling of noradrenaline and nitroglycerine by deriving the volume and drug mass concentration equations, based on pharmacokinetics and pharmacodynamics of the drugs. The closed-loop patient models are derived from the open-loop data obtained from the physiology-drug model with covariate as age. The proportional-integral controller is designed based on optimal values obtained from bacterial foraging-oriented particle swarm optimization algorithm. The controllers are implemented individually for each control variable such as aortic pressure and cardiac output (CO), irrespective of varying weights based on the relative gain array analysis which depicts the maximum influence of cardiac drugs on control variables. RESULTS: The physiology-drug model output responses are simulated using MATLAB. The controlled responses of aortic pressure and CO with infusion rate of cardiac drugs are obtained. The robustness of the controller is checked by introducing variations in cardiovascular model parameters. The efficiency of the controller during normal and abnormal conditions is compared using time domain analysis. CONCLUSIONS: The controller design was efficient and can be further improved by designing switching-based controllers. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6444840/ /pubmed/31031469 http://dx.doi.org/10.4103/ijp.IJP_612_18 Text en Copyright: © 2019 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Sowparnika, G. C.
Thirumarimurugan, M.
Sivakumar, V. M.
Vinoth, N.
Controlled infusion of intravenous cardiac drugs using global optimization
title Controlled infusion of intravenous cardiac drugs using global optimization
title_full Controlled infusion of intravenous cardiac drugs using global optimization
title_fullStr Controlled infusion of intravenous cardiac drugs using global optimization
title_full_unstemmed Controlled infusion of intravenous cardiac drugs using global optimization
title_short Controlled infusion of intravenous cardiac drugs using global optimization
title_sort controlled infusion of intravenous cardiac drugs using global optimization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444840/
https://www.ncbi.nlm.nih.gov/pubmed/31031469
http://dx.doi.org/10.4103/ijp.IJP_612_18
work_keys_str_mv AT sowparnikagc controlledinfusionofintravenouscardiacdrugsusingglobaloptimization
AT thirumarimuruganm controlledinfusionofintravenouscardiacdrugsusingglobaloptimization
AT sivakumarvm controlledinfusionofintravenouscardiacdrugsusingglobaloptimization
AT vinothn controlledinfusionofintravenouscardiacdrugsusingglobaloptimization